The role of ceramide chain length distribution on the barrier properties of the skin lipid membranes  by Mojumdar, E.H. et al.
Biochimica et Biophysica Acta 1838 (2014) 2473–2483
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe role of ceramide chain length distribution on the barrier properties of
the skin lipid membranesE.H. Mojumdar, Z. Kariman, L. van Kerckhove, G.S. Gooris, J.A. Bouwstra ⁎
Leiden Academic Center for Drug Research, Department of Drug Delivery Technology, Gorlaeus Laboratories, University of Leiden, Leiden, the Netherlands⁎ Corresponding author at: Department of Drug Deliver
Center for Drug Research, Einsteinweg 55, 2333 CC Leiden
527 4208; fax: +31 71 527 4565.
E-mail address: bouwstra@chem.leidenuniv.nl (J.A. Bo
http://dx.doi.org/10.1016/j.bbamem.2014.05.023
0005-2736/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 6 December 2013
Received in revised form 25 April 2014
Accepted 19 May 2014
Available online 27 May 2014
Keywords:
Pig ceramides
Stratum corneum
Lipid mixtures
Infrared spectroscopy
X-ray diffractionThe skin barrier function is provided by the stratum corneum (SC). The lipids in the SC are composed of three
lipid classes: ceramides (CERs), cholesterol (CHOL) and free fatty acids (FFAs) which form two crystalline lamel-
lar structures. In the present study, we investigate the effect of CER chain length distribution on the barrier prop-
erties of model lipid membranes mimicking the lipid composition and organization of SC. The membranes were
prepared with either isolated pig CERs (PCERs) or synthetic CERs. While PCERs have a wide chain length distri-
bution, the synthetic CERs are quite uniform in chain length. The barrier properties were examined by means
of permeation studies using hydrocortisone as amodel drug. Our studies revealed a reduced barrier in lipidmem-
branes prepared with PCERs compared to synthetic CERs. Additional studies revealed that a wider chain length
distribution of PCERs results in an enhanced hexagonal packing and increased conformational disordering of
the lipid tails compared to synthetic CERs, while the lamellar phases did not change. This demonstrates that
the chain length distribution affects the lipid barrier by reducing the lipid ordering and density within the lipid
lamellae. In subsequent studies, the effect of increased levels of FFAs or CERs with a long acyl chain in the
PCERs membranes was also studied. These changes in lipid composition enhanced the level of orthorhombic
packing, reduced the conformational disordering and increased the barrier of the lipidmembranes. In conclusion,
the CER chain length distribution is an important key factor for maintaining a proper barrier.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The major role of the skin is to protect the body from the environ-
ment by providing an exceptionally efﬁcient barrier. This physical barri-
er is located in the outer layer of the skin known as the stratumcorneum
(SC). The SC forms the rate limiting step for the penetration of drugs and
other substances into the skin. Due to this role, it is important to under-
stand the structure of the SC in relation to the skin barrier inmore detail.
The composition of the SC is exclusive. It consists of dead ﬂattened
protein rich cells referred to as corneocytes being surrounded by inter-
cellular lipids. These lipids greatly contribute to the barrier function of
the skin. The main lipid classes in the SC are ceramides (CERs), choles-
terol (CHOL) and free fatty acids (FFAs) in an approximately equimolar
ratio [1–6]. In human and pig SC the lipids form two coexisting crystal-
line lamellar phases, referred to as the long periodicity phase (LPP)with
a repeat distance of around 13 nmand the short periodicity phase (SPP)
with a repeat distance of about 6 nm [7,8]. Apart from the lamellar
phases, the arrangement of these lipids within the lipid lamellae, that
is the compactness of the lipid chain packing, is also important for they Technology, Leiden Academic
, the Netherlands. Tel.: +31 71
uwstra).skin barrier. This arrangement is referred to as the lateral packing. At
skin temperature (~32 °C), the human SC lipids dominantly adopt a
very dense orthorhombic packing. However, a small subpopulation of
lipids is also present in a less dense hexagonal organization [7,9–12].
Both the lamellar phases and lateral packing are important and have
been shown to play a role in the skin barrier function [13–16].
Further in-depth analysis of the SC lipid composition revealed differ-
ent subclasses of CERs and the chain length distribution of CERs and
FFAs in the SC. So far 12different subclasses of CERs have been identiﬁed
in the human SC, while in pig SC only 6 subclasses are present [1,4,5,17].
The CERs vary widely in their head group architecture and chain length
distribution. Some of the CER classes have a very exceptional molecular
architecture with a linoleic acid linked to a very long fatty acid chain.
These CER subclasses are known as acyl CERs. The CERs are the key com-
ponents in the skin barrier as they play a crucial role in maintaining this
barrier [18]. In particular a reduction or complete abduction of the acyl
CERs leads to an increased formation of the SPP and there are strong in-
dications that this also leads to a reduced skin lipid barrier [13,19–21].
The FFAs present in native human SC are mainly saturated and range
in chain length from C14 to C34 [20,22,23]with an average chain length
between C20 and C22. It has been reported that the presence of FFAs en-
hances the formation of the orthorhombic lateral packing [24].
In our present study, we aimed to compare the barrier properties of
lipid membranes prepared from isolated pig CERs (PCERs) with those
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mimics that of the PCERmixture. As each PCER subclass displays amulti-
ple variation in chain length, in contrast to the synthetic CER composition
having only 3 different chain lengths, a comparison between mixtures
prepared with PCERs and synthetic CERs provides information on the
role the chain length distribution plays in the skin lipid organization
and barrier properties. In addition, the inﬂuence of increased levels of i)
an acyl CER subclass, knownas CEREOS (esteriﬁed -hydroxysphingosine,
an acyl CER, see Fig. 1), and ii) FFAs on the barrier properties have also
been examined. To accomplish our endeavors, we used small angle X-
ray diffraction (SAXD) to elucidate the lamellar phases and Fourier trans-
form infrared spectroscopy (FTIR) to examine the lateral packing, the
conformational ordering and the mixing properties of the lipid mixtures.
In vitro permeation studies were performed using a lipid model mem-
brane cast on a porous support, referred to as the stratum corneum sub-
stitute (SCS) [25,26]. As model drug we used hydrocortisone.
2. Materials and method
2.1. Materials
Five subclasses of synthetic CERswere used in our studies. These are
an ester linked omega-hydroxyl acyl chain (30 carbons in the acyl chain
(C30)) with a sphingosine chain (C18) referred to as CER EOS (C30), a
non-hydroxy acyl chain (C24) linked to a sphingosine base (C18) re-
ferred to as CER NS (C24), a non-hydroxy acyl chain (C24 or C16) linked
to a phytosphingosine base referred to as CER NP (C24) and CER NP
(C16), respectively, an alpha-hydroxy acyl chain linked to a sphingosine
base referred to as CER AS (C24), and an alpha-hydroxy acyl chain (C24)
linked to a phytosphingosine base referred to as CER AP (C24). The
number between parentheses indicates the number of carbon atoms
present in the acyl chain of the CER subclass. The molecular structure
of the various synthetic CERs is provided in Fig. 1. All the CERs were
kindly provided by Evonik (Essen, Germany). The FFAs with a chain
length of C16:0, C18:0, C20:0, C22:0, C23:0, C24:0 or C26:0 are obtained
from Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany). CHOL,OH
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Fig. 1.Molecular structure of the synthetic CERs used in the present study. The CER con-
sists of an acyl chain ranging from 24 to 30 carbons linked to a sphingoid base through
an amide linkage.trypsin (type III, from bovine pancreas) and trypsin inhibitor (type II-S
from soybean) were also purchased from Sigma-Aldrich Chemie
GmbH (Schnelldorf, Germany). The perdeuterated FFAs with chain
lengths of C16:0 and C22:0 and hydrocortisone were purchased from
Larodan (Malmo, Sweden). The perdeuterated FFAs with chain lengths
of C14:0, C18:0, and C20:0 were obtained from Cambridge Isotope Lab-
oratories (Andover MA, USA). Nucleopore polycarbonate ﬁlter disks
(pore size 50 nm) were obtained from Whatman (Kent, UK). All sol-
vents were of analytical grade and supplied by Labscan (Dublin,
Ireland). The water was of Millipore quality.
2.2. Isolation and extraction of PCER
Fresh pig skin was obtained from the Central Veterinary Institute in
Lelystad in the Netherlands. First, the hairs were removed with a razor
blade. Then the pig skin was defatted and dermatomed at a thickness
of 600 μm. The SC was isolated by trypsin digestion (0.1% in a
phosphate-buffered saline solution) as described previously [27]. SC
lipids were extracted using the method of Bligh and Dyer [28]. Brieﬂy,
ﬁrst a series of chloroform:methanol extractions in various ratios (1:2,
1:1 and 2:1 v/v) was performed for 1 h at 37 °C. The extracts were
then combined and treated with 2.5% KCl in demi-water to create an
aqueous phase. The organic phase was collected, evaporated using a ro-
tary evaporator and subsequently applied onto a silica gel 60 column
after being redissolved in a suitable volume of chloroform:methanol
(2:1). Then the various lipid classes were eluted sequentially using a se-
ries of solventmixtures as published previously [27]. The lipid composi-
tion of the collected fractions was examined by one dimensional high
performance thin layer chromatography (HPTLC), as described previ-
ously [27]. Then the fractions that contained only CERs were combined
and the composition was analyzed. For quantiﬁcation of the CER sub-
classes, HPTLC was performed: authentic standards (mixtures of 7 dif-
ferent CERs) and the isolated PCERs were run in parallel. To perform
the quantiﬁcation 12 different amounts of the CER standard solution
and isolated PCER solutionwere applied on the plate. The quantiﬁcation
was performed after charring, using a photodensitometer with peak in-
tegration (Biorad, GS 800). The linear part of the calibration curveswere
used for calculating the relative levels of the PCER subclasses.
2.3. Mass spectrometry analysis
The PCERswere further analyzed by liquid chromatography coupled
to mass spectrometry (LC/MS) in order to investigate the chain length
distribution. A detailed description of the lipid analysis is given else-
where [17]. In short, the PCER sample was redissolved in chloroform:
methanol:heptane (2.5:2.5:95) to a ﬁnal concentration of 1 mg/mL.
10 μL of sample was injected using an HPLC system (Waters, Thermo,
Finnigan, San Jose, CA). The HPLC was coupled to a mass spectrometer
(TSQ Quantum, Thermo, Finnigan, San Jose, CA) to analyze the PCER
composition. The separation of the PCER was achieved by using a nor-
mal phase column (PVA-sil, YMC, Kyoto, Japan) while analyzing in pos-
itive ion mode. The software Xcalibur was used for data acquisition.
2.4. Compositions of stratum corneum substitute (SCS)
For the preparation of the SCS, synthetic CERs or PCER, CHOL and
FFAs were used. The two compositions of the synthetic CERs with
their corresponding molar ratios are provided in Table 1. One of these
compositions is based on a CER subclass composition of pig SC reported
earlier [27,29] and is referred to as CERcontrol. The other synthetic CER
composition mimics the composition of the PCERs isolated in the
present study and is referred to as CERspig. The composition of the FFA
mixture was comprised of seven different FFAs. The name, chain length
and themolar ratios of the FFAmixture are provided in Table 1. This FFA
composition is based on that reported for human SC [30]. In a few FTIR
experiments, the protonated FFAs were replaced by deuterated FFAs
Table 1
The composition andmolar ratios of the synthetic CERs and FFAs used in the current study
are presented in the table. The synthetic CERmixture used in previous studies (CERcontrol)
and the synthetic CER mixture (CERspig) mimicking the subclass composition of isolated
pig CERs used in the present study are provided. In addition the FFAs molar ratio is given.
CER name and
chain length
Molar ratio (%)
in CERcontrol
Molar ratio (%)
in CERspig
FFA name and
chain length
Molar
ratio (%)
CER EOS (C30) 15 13.8 Palmitic acid (c16) 1.8
CER EOP (C30) – 0.9 Stearic acid (c18) 4.0
CER NS (C24) 51 44.2 Arachidic acid (c20) 7.7
CER NP (C24) 16 8.8 Behenic acid (c22) 42.6
CER AS (C24) 4 5.9 Tricosylic acid (c23) 5.2
CER NP (C16) 9 16.8 Lignoceric acid (c24) 34.7
CER AP (C24) 5 9.7 Cerotic acid (c26) 4.1
Total 100 100 Total 100
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and C24:0 at molar ratios of 1.8, 4.0, 7.6, 47.8 and 38.8 respectively. In
total, six different model membrane systems have been prepared. The
detailed composition and themolar ratios of thesemodel types are pro-
vided in Tables 1 and 2.
2.5. Preparation of the SCS for diffusion and SAXD studies
For each of the lipid mixtures the appropriate amount of individual
lipids was combined, after which the organic solvent chloroform:meth-
anol (2:1) was evaporated under a ﬂow of nitrogen. Then the lipids
were redissolved in a hexane:ethanol (2:1) solution andused to prepare
the SCS. To spray the lipid mixtures on Whatman nucleopore polycar-
bonate ﬁlters disks, a Camag Linomat IV (Muttenz, Switzerland) was
used with an extended y-axis arm [31]. A Hamilton syringe (100 μL)
was inserted in the Linomat andused to spray a selected volumeof sam-
ple solution from a distance of approximately 1mmonto the porous ﬁl-
ter substrate under a gentle stream of nitrogen ﬂow. With the y-axis
arm, the Linomat is capable of spraying lipids in a square shape (8 by
8 mm), by a continuous zigzag movement. The spraying ﬂow rate was
set to 5.0 μL/min and 0.9 mg of lipids per membrane was sprayed.
After spraying, the SCS was equilibrated for 12 min between 70 and
80 °C depending on the selected lipid composition. After equilibration,
the membranes were gradually cooled to room temperature and mea-
sured by SAXD.
2.6. Sample preparation for FTIR studies
The preparation method differed slightly from the above described
method. 1.5 mg of lipids was dissolved in a chloroform:methanol
(2:1) solution. The spraying area was 1 × 1 cm2 on a ZnSe (zinc sele-
nide) window. The samples were equilibrated for about 10 min at ap-
proximately 80 °C and cooled gradually to room temperature.
Subsequently, the lipid layers were covered with 25 μL deuterated ace-
tate buffer (pH 5.0) and stored at 37 °C for 15 h to fully hydrate the sam-
ple. Although the FTIR sample preparation is slightly different comparedTable 2
The various lipid mixtures with their composition and molar ratios used to prepare the SCSs. T
lipid lateral packing and the wavenumbers of the CH2 stretching vibrations indicative for the co
hydrocortisone across the SCSs with their associated standard deviation is also shown.
Denotation in the
text
Lipid composition and molar ratio Lamellar organization
(25 °C)
SCScontrol CERcontrol/CHOL/FFA (1:1:1)⁎ LPP, SPP
SCSspig CERspig/CHOL/FFA (1:1:1)⁎ LPP, SPP
pigSCS111 PCER/CHOL/FFA (1:1:1) LPP, SPP
pigSCS112 PCER/CHOL/FFA (1:1:2) SPP
pigSCSEOS111 PCER + 20 mol% CER EOS/CHOL/FFA (1:1:1)⁎⁎ LPP, SPP
pigSCSEOS11 PCER + 20 mol% CER EOS/CHOL (1:1) LPP, SPP
⁎ The synthetic CER mixture was prepared based on CER molar ratios presented in the Table
⁎⁎ The mixture was prepared using PCERs with an addition of 20 mol% of CER EOS. The CER,to SCS membrane preparation, for clarity the SCS term will be used
throughout the paper.
2.7. SAXD methodology
SAXDwas used to examine the lamellar organization. The scattering
intensity I (in arbitrary units)wasmeasured as a function of the scatter-
ing vector q (in reciprocal nm). The latter is deﬁned as q= (4πsinθ) / λ,
in which θ is the scattering angle and λ is the wavelength. From the po-
sitions of a series of equidistant peaks (qn), the periodicity, or d-spacing
of a lamellar phasewas calculated using the equation d= 2nπ / qn, with
n being the order number of the diffraction peak. One-dimensional in-
tensity proﬁleswere obtained by the transformation of the 2D SAXDde-
tector pattern from Cartesian (x,y) to polar (ρ,θ) coordinates and
subsequently integrating over θ. All measurements were performed at
the European Synchrotron Radiation Facility (ESRF, Grenoble) using sta-
tion BM26B. The X-raywavelength and the sample-to-detector distance
were 0.1033nmand2mrespectively. Diffraction datawere collected on
a PILATUS 1 M detector with 1043 × 981 pixels of 172 μm spatial reso-
lution. The spatial calibration of this detectorwas performed using silver
behenate (d= 5.838 nm for AgBeh). The SCS (prepared on a polycar-
bonate ﬁlter disk) was mounted parallel to the primary beam in a sam-
ple holder with mica windows. The diffraction data were collected for
10 min at 25 °C.
2.8. FTIR methods
The FTIR instrument consists of a BIORAD FTS4000 FTIR spectrome-
ter (Cambridge MA, USA) equipped with a broad-band mercury cadmi-
um telluride detector, cooled by liquid nitrogen. The sample cell was
closed by two ZnSe windows. The sample was under continuous dry
air purge starting 30 min before the data acquisition. The spectra were
collected in transmission mode with a co-addition of 256 scans at
1 cm−1 resolutions during 4 min. In order to detect phase transitions,
the sample temperature was increased at a heating rate of 0.25 °C/min
resulting in a 1 °C temperature rise per recorded spectrum. The spectra
were collected between 0 °C and 90 °C and deconvoluted using a half-
width of 4 cm−1 and an enhancement factor of 1.7. The software used
for data reductionwasWin-IR pro 3.0 fromBiorad. The linear regression
curve ﬁtting method was used to determine the transition temperature
of the lipid mixtures. The CH2 symmetric stretching vibration frequen-
cies in the spectra were used to study the orthorhombic to hexagonal
phase transition in the temperature range of 20–40 °C and the hexago-
nal to liquid phase transition in the temperature range between 50 and
80 °C. The CH2 rocking vibrations were used to study the orthorhombic
to hexagonal phase transition into more details.
2.9. Diffusion setup
Diffusion studies were performed with PermeGear inline diffusion
cells (Bethlehem PA, USA) with a diffusion area of 0.282 cm2. The SCSshe lipid lamellar organization with their corresponding repeat distances is presented. The
nformational ordering are also given in the table. The steady state ﬂux of the model drug
Repeat distance (nm) Lateral packing
(32 °C)
Conformational
ordering (32 °C)
Steady state ﬂux
(μg/cm2/h)
12.1, 5.3 Orthorhombic 2850.1 0.04 ± 0.01
12.1, 5.3 Orthorhombic 2849.9 0.06 ± 0.03
12.5, ~5.7 Hexagonal 2850.9 0.76 ± 0.14
5.8 Slightly orthorhombic 2850.7 0.40 ± 0.01
13.1, ~5.8 Slightly orthorhombic 2851 0.31 ± 0.07
13.1, ~4.4 Slightly orthorhombic 2850.7 0.54 ± 0.07
1.
CHOL and FFA molar ratios are equimolar.
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buffered saline (PBS) served as the acceptor phase solution during the
permeation studies. The phosphate-buffered saline (PBS) solution was
prepared by adding NaCl, Na2HPO4, KH2PO4 and KCL in MQ water in
concentrations of 8.13, 2.87, 0.20 and 0.19 g/L respectively; the buffer
was adjusted to a pH of 7.4, ﬁltrated and degassed for 15 min with
helium. The donor phase solution of the diffusion cells was prepared
with themodel drug hydrocortisone (MW=364 g) dissolved in acetate
buffer (NaAc ∗ 3H2O solution acidiﬁed with acetic acid (CH3CO2H) to
pH 5) and 1.4 mL of hydrocortisone solution was applied in the donor
compartment at a saturated concentration of 0.3 mg/mL. A saturated
concentration was used to obtain a maximum thermodynamic activity.
The donor compartmentwas closedwith an adhesive tape formaintain-
ing occlusive conditions throughout the experiment. The molecular
structure of the drug compound hydrocortisone is presented in Fig. 2A.
The acceptor phase with PBS (pH 7.4) was perfused at a ﬂow rate of
approximately 2 mL/h with a ﬂow pump (Ismatec IPC pump; IDEX
Health & Science GmbH, Germany) and the acceptor compartments
were stirred with the magnetic stirrers at 160 rpm to prevent accumu-
lation of themodel drug. A fraction collector (Isco Retriever IV; Teledyne
Isco, USA)was used to collect the acceptor ﬂuid in 10mL glass vials each
hour. The exact volume per collected fraction was determined by
weighing. The temperature of the diffusion cells during permeation
was controlled at physiological human skin temperature of approxi-
mately 32 °C by a thermo-stated water bath (Thermostat from Lauda
Dr. Wobser GmbH; Lauda-Koenigshofen, Germany). The steady state
ﬂux (Jss) values between time intervals of 5 and 15 h were calculated
from the cumulative plot ﬂux values of the permeating compound.
The slope of the linear part of the cumulative plot represents the steady
state ﬂux. A schematic drawing of the diffusion setup is presented in
Fig. 2B.
2.10. HPLC method
Quantiﬁcation of the drug compoundhydrocortisonewas carried out
by high performance liquid chromatography (HPLC) analysis. The HPLC
system consisted of a Spectra systemUV2000 detector (Thermo Separa-
tion Products Inc., California, USA), a high precision pump model 300
(Thermo Separation Products Inc., California, USA) and a solvent recy-
cler, complemented with an auto injector (Gilson 234 Autoinjector;
Gilson Inc., Middleton, USA). The C18 reversed phase column (Alltima,
50 μm id, 125 × 4.0 mm) was used during the experiment. The mobile
phase used for the HPLC analysis contained helium degassed mixtures
of acetonitrile:Millipore water at a 40:60 (v/v) ratio. The UV-detection
wavelength of 243 nm was used for a hydrocortisone drug molecule.
The ﬂow rate of themobile phase was set to 1 mL/min. Series of calibra-
tion samples were run in parallel with each series of the permeation
samples to separate and quantify the drug compound. The Software
ADchrom was used to analyze and integrate the HPLC data.
2.11. Statistical analysis
Statistical analysis was performed using the Excel spreadsheet ver-
sion 2010. Unpaired two-tailed T-test and one-way ANOVA were per-
formed, both with a signiﬁcance level set at P b 0.05.
3. Results
3.1. CER composition: quantiﬁcation and chain length distribution in PCERs
After isolation of PCERs from pig SC, the composition of the PCERs
was determined by HPTLC. Fig. 3 shows the molar composition of CER
subclasses in the isolated PCER mixture. CER NS is present at a high
level, namely 44 mol%, while the abundance of CER EOS is 13 mol%. A
small level of CER EOP is also present. This composition of PCERs is sim-
ilar as reported in the literature, although the most hydrophilic CERsubclasses are slightlymore abundantly present compared to the previ-
ous published composition [32]. To obtain information on the chain
length distribution of the various CER subclasses, LC/MSwas performed
and the results are provided in Fig. 4. In the 3-D mass spectrum, the
same subclasses of PCER mixture are shown conﬁrming the HPTLC re-
sults. Furthermore, the LC/MS results also show a large distribution in
CER chain lengths. The most abundant chain lengths are observed for
the CER NS subclass ranging from C32 to C40 (total chain length:
sphingoid base + acyl chain). The shorter chain lengths are observed
most abundantly in the CER AdS and CER AS subclasses with a total
chain length of C34 for CER AdS and C33–C34 for the CER AS (marked
by x in the chromatogram).
3.2. The CER chain length distribution affects the lipid barrier function
To investigate the effect of lipid composition on the skin barrier, dif-
fusion studies were performed using hydrocortisone as model drug.
Fig. 5 displays the mean ﬂux proﬁles of all the SCSs used in our study.
The steady state ﬂuxes of all SCSs with their standard deviation are pro-
vided in Table 2.
First, wewill focus on the SCSs preparedwith the synthetic CERmix-
tures. The hydrocortisone steady state ﬂux across SCScontrol (prepared
with the CERcontrol we used in previous studies), revealed a steady
state ﬂux of 0.04 ± 0.01 μg/cm2/h. When comparing this mixture with
the SCSspig prepared with the CERspig, the hydrocortisone steady state
ﬂux is 0.06 ± 0.03 μg/cm2/h which is not signiﬁcantly different from
that of the SCScontrol. In parallel, we measured the hydrocortisone ﬂux
across SCS prepared from PCERs. The steady state ﬂux of the pigSCS111
prepared with PCER/CHOL/FFA (1:1:1) is signiﬁcantly increased to a
value of 0.76 ± 0.14 μg/cm2/h, which is approximately 12 times higher
compare to the SCSspig.
3.3. The addition of CER EOS and/or FFA reduces the hydrocortisone ﬂux
We also examined the effect on the hydrocortisone ﬂux after in-
creasing the levels of CER EOS in the SCS. The pigSCSEOS11 prepared
with (PCER + 20 mol% additional CER EOS)/CHOL (1:1) resulted in a
steady state ﬂux of 0.54 ± 0.07 μg/cm2/h. The addition of FFA to this
mixture (pigSCSEOS111) resulting in a composition of (PCER + 20 mol%
CER EOS)/CHOL/FFA (1:1:1) reduced the steady state ﬂux further to
0.31 ± 0.07 μg/cm2/h. A further increase of FFA in the PCER/CHOL/FFA
mixture resulting in a molar ratio 1:1:2 (pigSCS112) also reduced the
steady state ﬂux to 0.40 ± 0.01 μg/cm2/h compared to the steady state
hydrocortisone ﬂux obtained with pigSCS111.
As we obtained differences in the hydrocortisone steady state ﬂux
across the various SCSs indicating differences in lipid organization, we
decided to study the lipid organization of these SCSs. For this reason
SAXD and FTIR studies were performed.
3.4. Lamellar phase behavior of the various lipid mixtures
SAXD was used to study the lamellar organization of the SCSs. The
detected lipid lamellar phaseswith their corresponding repeat distances
are provided in Table 2 for various lipid mixtures. First the SCSs pre-
pared from synthetic CERs are described (see Fig. 6A, top — SCScontrol,
bottom — SCSspig). The SCSs prepared with synthetic CERs, either
SCScontrol or SCSspig, displayed two lamellar phaseswith repeat distances
of 12.1 and 5.3 nm being the LPP and SPP, respectively. The peaks at q=
0.52, 1.05, 1.57 and 2.1 nm−1 indicate the 1st, 2nd, 3rd and 4th order
peaks attributed to the LPP with a repeat distance of 12.1 nm whereas
the peaks at q = 1.18 and 2.36 nm−1 indicate the 1st and 2nd order
peaks attributed to the SPP respectively with a repeat distance of
5.3 nm. No signiﬁcant differences were noticed between the diffraction
proﬁles of these two SCSs.
When focusing on the SCSs prepared with isolated PCERs, we ﬁrst
present the results obtained with pigSCS111 (Fig. 6B). The diffraction
OO
OHHO
HO
H
H
H
BA
Donor compartment
Acceptor compartment
Drug
Stratum corneum
substitute
Flow through
(PBS buffer)
Fig. 2. (A) The molecular structure of the drug compound hydrocortisone (MW= 364 g) used for permeation studies. (B) A schematic drawing of the diffusion cell.
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12.5 and approximately 5.7 nm, respectively. In this pattern, the 1st and
3rd order peaks of the LPP located at q=0.50 and 1.50 nm−1 are clearly
visible along with the peak from crystalline CHOL (q= 1.8 nm−1). The
2nd order LPP peak is visible as a small shoulder on the left side of the
1st order SPP peak positioned at q = 1.10 nm−1. In additional studies
we elevated either the FFA level or the CER EOS level. When focusing
on an increased level of FFA, we did notice changes in the lamellar
phases. In the pigSCS112 the lipids form only the SPP with a repeat
distance of 5.8 nm (Fig. 6C). The diffraction peaks at q= 1.07, 2.15 and
3.22 nm−1 indicate the 1st, 2nd and 3rd order peaks of SPP respectively.
Two SCSs were examined with an addition of 20 mol% CER EOS, i.e.,
pigSCSEOS11 and equimolar pigSCSEOS111 (Fig. 6D, top— pigSCSEOS111, bot-
tom— pigSCSEOS11). In both SCSs, the LPPwas abundantly present with a
slightly increased repeat distance to approximately 13.1 nmcompared to
the pigSCS111 (not enriched with CER EOS). In the pigSCSEOS11, the lipids
mainly adopt the LPP. As the 3rd order diffraction peak attributed to the
LPP is quite broad, most probably this peak is also attributed to another
phase indicating a slight phase separation. In the diffraction proﬁle of
the pigSCSEOS111 we notice an asymmetric 2nd order diffraction peak of
the LPP, suggesting that not only the LPP but also the SPP is formed
(peak positioned at q= ~1.07 nm−1, shoulder indicating the 1st order
diffraction peak).
3.5. Conformational ordering and lateral packing of the lipid mixtures
determined by FTIR
Besides the lamellar phases, the lateral packing and conformational
disordering may also play a role in the barrier properties of the SCS. ToA
Fig. 3. High performance thin layer chromatography of isolated PCERs. (A) The CER subclasses
HPTLC plate shows the corresponding bands of the isolated PCER.investigate the lateral packing and conformational disordering the
SCSs were examined by FTIR.3.5.1. Conformational ordering
TheCH2 symmetric stretching frequency provides information about
the conformational ordering of the lipid tails in the mixtures. A low
(~2848 cm−1)wavenumber of the CH2 symmetric stretching vibrations
indicates the presence of a highly ordered lipid organization (either
hexagonal or orthorhombic), while a high (~2853 cm−1) wavenumber
indicates a liquid disordered phase [33]. The CH2 symmetric stretching
position in the FTIR spectrum is examined as a function of temperature
and the results are provided in Fig. 7: two clearly distinct groups of
stretching vibrations are detected. Two spectra with low CH2 stretching
frequencies are obtained with SCScontrol and SCSspig: at 10 °C CH2
stretching frequencies of around 2849.5 cm−1 are observed. The fre-
quencies gradually shift to higher values until 30 °C. The low values in-
dicate conformational ordering of the lipids in the SCS in this
temperature range. A further increase in temperature from 30 to 40 °C
results in a shift of CH2 symmetric frequency from 2849.5 to
2851.3 cm−1 for the SCScontrol and 2850.5 cm−1 for the SCSspig. These
changes are based on a phase transition from orthorhombic to a hexag-
onal lateral packing (see below). Between 40 and 60 °C a further grad-
ual increase in frequency was observed indicating an increased
conformational disordering of the chains. A subsequent further increase
in temperature from 60 to 80 °C results in a large frequency shift from
2851.3 to 2853.3 cm−1 for the SCScontrol and 2850.5 to 2853.4 cm−1
for the SCSspig, demonstrating the formation of a liquid phase in this
temperature range. CHOL
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Fig. 4. 3-Dmulti-mass chromatogram for PCER analysis showing different subclasses of PCER and their chain length distribution. The labeled ‘+’ signs are unknown lipid classes and the ‘x’
indicates the increased abundance of the very short CERs in the pig SC. The PCERs prevail with a wider chain length distribution compared to the synthetic CERs.
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symmetric stretching frequencies. In the spectrum of pigSCS111 at
10 °C the CH2 symmetric frequency is located at 2850.0 cm−1. This is
at higher values than in the spectra of the mixtures prepared with the
synthetic CERs. Between 10 °C and 50 °C a gradual increase in the CH2
symmetric frequency is observed from 2850.0 cm−1 to 2851.2 cm−1.
Increasing the temperature above 50 °C results in a large shift of the
CH2 symmetric stretching frequencies to 2853.2 cm−1 suggesting the
presence of a liquid phase. The spectrum of the pigSCS11 (equimolar
PCER/CHOL mixture) has an initial CH2 symmetric frequency of
2850.6 cm−1 at 10 °C and a gradual increase is observed until 50 °C
with a CH2 symmetric frequency of 2851.4 cm−1. Beyond 50 °C, a tran-
sition occurred with a frequency of 2853.4 cm−1 at 85 °C, indicative of
the presence of a liquid phase.
In addition, we also studied the effect of an increased level of either
CER EOS or FFA in the mixtures. First we will present the studies with
SCS with increased EOS levels, namely pigSCSEOS111 and pigSCSEOS11.
The FTIR spectra of both SCS exhibit a CH2 symmetric stretching frequen-
cy of 2850.3 cm−1 at 10 °C. Increasing the temperature of the
pigSCSEOS111, the frequency gradually shifts from 2850.3 to 2851.3 cm−1
at 60 °C. Subsequently a clear shift is noticed between 60 and 80 °C
with a ﬁnal CH2 symmetric frequency of 2853.6 cm−1 at 80 °C. For the
pigSCSEOS11, the symmetric stretching frequency remains similar untilFig. 5. Flux proﬁles of hydrocortisone across SCSs prepared from various lipid mixtures.
The SCSs are prepared from either isolated PCERs or synthetic CERs. Figure legend
shows the denotation of different model lipid mixtures used in permeation studies. For
the detailed compositions and molar ratios, see Tables 1 and 2. The SCSs prepared from
PCERs prevail with a higher permeation ﬂux than the SCSs prepared from synthetic CERs.50 °C after which from 50 to 80 °C a symmetric frequency shift occurs
from 2851.2 to 2853.7 cm−1 indicating the transition from an ordered
to a disordered liquid phase. The stretching frequency of the pigSCS112
starts with 2850.1 cm−1 at 10 °C and increased gradually until 65 °C to
2851.7 cm−1. A further increase in temperature results in an ordered–dis-
ordered transition with a CH2 symmetric frequency of 2853.3 cm−1 at
85 °C.
3.5.2. Lateral packing
The FTIR rocking frequencies provide information on the lateral
packing of the lipid chains. When the lipid tails in the mixtures adopt
an orthorhombic lateral organization, the contours of the rocking vibra-
tions in the FTIR spectrum are characterized by a doublet with rocking
frequencies at approximately 720 and 730 cm−1. This doublet is caused
by the interactions of the adjacent lipid chains via a short range coupling
[34]. On the contrary, when the lipids adopt a hexagonal phase, instead
of a doublet a singlet is observed at 721 cm−1 in the FTIR spectra. Due to
the less dense packing in the hexagonal organization no short range
coupling occurs. The CH2 rocking frequencies in the FTIR spectrum of
all model lipid mixtures are shown in the temperature range from 20
to 40 °C in Fig. 8. The lipid lateral packing of all the lipid mixtures are
provided in Table 2.
The FTIR spectra of the SCScontrol and SCSspig showa strong doublet in
the rocking vibration frequencies at approximately 720 and 731 cm−1
at 20 °C, indicative of the presence of the highly ordered orthorhombic
packing (Fig. 8A and B). A gradual increase in temperature results in a
gradual reduction in the intensity of the 730 cm−1 rocking frequency.
At 40 °C only a singlet is observed, indicating that the orthorhombic
phase disappeared.
The rocking vibrations in the spectrum of the pigSCS111 exhibits the
presence of a broad intense contour at approximately 720 cm−1 at
20 °C in the spectrum revealing the presence of mainly a hexagonal
packing (Fig. 8C). However, a weak shoulder is also observed at
~730 cm−1 suggesting that a small population of lipids adopts an ortho-
rhombic organization at this temperature. When raising the tempera-
ture, the weak shoulder starts to disappear and the contour becomes a
singlet at around temperature of 30 °C. To examine the effect of the
level of FFA in the SCS on its lateral packing, we also measured the
pigSCS11 and pigSCS112. In the spectrum of the pigSCS11 a single rocking
vibration is observed in the whole temperature range studied and
therefore in this mixture, only a hexagonal lateral organization is pres-
ent (Fig. 8D). In the pigSCS112, the spectrum of this SCS adopts a doublet
in the rocking FTIR spectra at 20 °C at frequencies of 731 and 720 cm−1
(Fig. 8E). This 731 cm−1 contour does not reduce in intensity when in-
creasing the temperature to 40 °C.
When focusing on the effects of CER EOS levels, we examined the
pigSCSEOS11 and pigSCSEOS111. In the spectrum of pigSCSEOS11 a broad
A B
C D
Fig. 6. SAXD diffraction proﬁle of different SCSs used in our study. The ﬁgure legend describes the denotation of the different lipid mixtures prepared. The detailed composition andmolar
ratios are given in Tables 1 and 2. In the SAXDproﬁles, theArabic numbers (1, 2, 3…) indicate the different diffraction orders of the LPP. TheRomannumbers (I, II…) indicate thediffraction
orders attributed to the SPP. Panel A— top: SCScontrol and bottom: SCSspig; panel D— top: pigSCSEOS111 and bottom: pigSCSEOS11. The peaks originating from crystalline CHOL domains are
indicated by an asterisk (*). The relatively shorter phase observed in panel D (bottom) is indicted by a hash (#) sign.
Fig. 7. The CH2 symmetric stretching frequency thermotropic response curves for the var-
ious SCSs. The higher CH2 symmetric stretching wavenumbers indicate higher conforma-
tional disordering values. Higher CH2 symmetric stretching wavenumbers are observed
for the SCSs prepared from PCERs while lower values are observed in the spectra of SCSs
prepared from synthetic CERs.
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observed in the FTIR rocking vibrations at 20 °C at approximately
720 cm−1 (Fig. 8F), suggesting the presence of mainly a hexagonal
phase, while a small population of lipids adopts an orthorhombic lateral
organization (shoulder at around 730 cm−1). Unlike the pigSCS111mix-
ture, the 730 cm−1 contour does not vanish upon heating until 40 °C. In
the spectrumof pigSCSEOS111 a strong doublet is observed in the rocking
vibration frequencies at 720 and 731 cm−1 at 20 °C (Fig. 8G). A gradual
increase in temperature beyond 20 °C results in a collapse of thedoublet
in this mixture: one singlet is observed at 40 °C indicating the absence
of the orthorhombic lateral packing.
In order to investigate whether phase separation occurs between
CER and FFA in the SCS, the protonated FFA was replaced by DFFA and
the splitting of the FTIR scissoring mode was examined. The use of
DFFA allows us to monitor whether CER and FFA participate in one lat-
tice or phase separate. When the DFFA and CER participate in an ortho-
rhombic lattice, due to the difference in frequencies, the CH2 and CD2
cannot interact with each other. As a result, no or only a weak doublet
is observed in the FTIR spectrum [35]. We particularly focused on two
SCSs: the CD2 scissoring vibrations in pigSCSEOS111 and pigSCS112, both
exhibiting an orthorhombic lateral packing. The results are provided
in Fig. 9A and B. In the spectrum of the pigSCSEOS111 a weak doublet is
detected at low temperature (10 °C) which dissolves when the temper-
ature is increased. The scissoring vibration turns into a singlet at around
20 °C and indicates that DFFA and CER are participating in the same lat-
tice. In case of pigSCS112, the doublet in the scissoring mode is stronger
at low temperatures and remains visible until 40 °C, suggesting phase
separation of FFA in an orthorhombic lattice.
4. Discussion
The aim of our current study is to examine whether SCSs prepared
from isolated PCERs do have a difference in permeability compared tomembranes prepared from synthetic CERs and whether the differences
in permeability can be explained by differences in the lipid composition
and subsequent organization. Furthermore, the effect of increased levels
of FFAs and CER EOS on the permeability as well as the lipid organiza-
tion was studied usingmixtures prepared with PCERs. As in the present
study the SCSs have been prepared from natural CERs, the extrapolation
of the results to the in vivo situation is more straight forward compared
to mixtures prepared from synthetic CERs. This is especially true when
varying the level of FFAs. Thus a phase transition from hexagonal to an
orthorhombic lateral packing is restricted by using mixtures with
A B C
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D
Fig. 8. Thermotropic CH2 rocking vibration frequencies as a function of temperature for various SCSs. The spectra are shown from a 20 to 40 °C temperature region and 32 °C is highlighted
as the permeation studies performed at this temperature (the skin temperature).
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length distribution, which are required for a proper mixing of the lipids
forming the two lamellar phases. In such mixtures, however, the lipids
form an orthorhombic packing. This is the reason why in previous stud-
ies the orthorhombic to hexagonal packing on the lipid barrier was
studied using diffusion studies carried out as a function of temperature.
These increased temperatures induce an orthorhombic to hexagonal
phase transition.
4.1. CER chain length distribution affects the lipid barrier
When comparing the steady state ﬂux of SCSs prepared from either
synthetic CERs or PCERs, we do notice a signiﬁcant difference: all SCSs
prepared from PCER containing mixtures exhibit higher steady state
ﬂuxes than observed with SCSs prepared using synthetic CERs. When
comparing the CER composition of SCSspig and pigSCS111, the CER sub-
class composition is very similar. However, the PCER subclasses have a
wide chain length distribution whereas the synthetic CER subclasses
display only three different acyl chain lengths and only a single
sphingoid base length. Therefore, these studies clearly show that chain
length distribution affects the permeability of the SCS quite drastically.
Then the question arises, whether a wider distribution of chain lengths
will affect the lamellar phases and/or the lateral organization conse-
quently resulting in an increased steady state ﬂux. When focusing on
the lamellar phases, no drastic differences were observed between
SCSspig and pigSCS111. In both SCSs, the LPP and the SPP coexist. Al-
though the repeat distances are somewhat different, namely with a
slight increase in the pigSCS111, this is not expected to be a major factorfor the increased steady state ﬂux in the pigSCS111. However, when we
focus on the lateral packing, differences are observed. While at around
32 °C, in the SCSspig, mostly an orthorhombic lateral packing is ob-
served, in the pigSCS111 mainly a hexagonal lateral packing prevails. In
addition, at 32 °C a higher conformational disordering is noticed in the
pigSCS111 (CH2 stretching vibrations at around 2851 cm−1) compared
to that in the SCSspig. The higher stretching vibration frequencies per-
haps indicate that, a small subpopulation of lipids may adopt a liquid
phase at this temperature which may facilitate the diffusion of a hydro-
cortisone drug compound by increasing the conformational disordering
in the lipid tails. However, at 32 °C the lamellar phases are still evident
from SAXDmeasurements. Therefore, the liquid phase present at 32 °C
is expected to be located in the lipid lamellae coexisting with the more
crystalline domains. Both the presence of mainly a hexagonal lateral
packing as well as an increased conformational disordering may be re-
sponsible for the increased steady state ﬂux of the pigSCS111 compared
to the SCSspig. Most probably the mismatch between the various chain
lengths within the lipid lamellae is responsible for these observed
differences.4.2. Levels of FFA and CER EOS affect lipid barrier
An increased level of CER EOSor FFA in thepigSCS reduces the steady
state ﬂux and therefore increases the lipid barrier. While the levels of
CER EOS and FFA were both increased two-fold, the increase in CER
EOS level reduced the steady state ﬂux most drastically. This is indica-
tive of an increased lipid barrier of SCSs prepared from PCERs.
A B
Fig. 9. FTIR spectra of the deuterated samples. (A) The CD2 scissoring frequency of the
pigSCSEOS111 prepared with DFFA. (B) The CD2 scissoring frequency of the pigSCS112 pre-
pared with DFFA. The absence and/or presence of a very weak doublet at 32 °C indicates
that the lipids are forming a homogeneous mixture and very little lipids eventually exist
as phase separated domains.
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synthetic CER containing SCSs.
When focusing on the lamellar organization of the SCS, an increase
in the level of CER EOS, i.e., pigSCSEOS111, results in only the formation
of the LPP. In previous studies using SCS from synthetic CERs, it was
shown that an increased presence of the LPP results in a reduction in
the steady state ﬂux [25]. When focusing on the lateral organization a
slight increase in the orthorhombic organization was observed at
32 °C, the temperature of the SCS during the diffusion studies, while
the conformational ordering remained very similar. Therefore in case
of enrichment in CER EOS, the reduced steady state ﬂux is most proba-
bly due to both the increased formation of the LPP and the increased
presence of the orthorhombic lateral packing. This is different for in-
creased levels of FFA in the SCS. As in this pigSCS112 only a SPP is present.
This is expected to increase the steady state ﬂux of hydrocortisone [25].
However, in this SCS at 32 °C, a slight increase in the orthorhombic or-
ganization together with an increased conformational ordering in the
CH2 symmetric stretching vibration is observed compared to that in
pigSCS111. Therefore, in this case, mainly the changes in conformational
ordering and lateral organization will contribute to the reduced steady
state ﬂux across the SCS, while the presence of only the SPP is expected
to counteract the reduced permeability.
Very interestingly, in the FTIR spectrumof the enriched EOS contain-
ing SCSs (pigSCSEOS111), the rocking vibration at 730 cm−1 strongly re-
duces when the temperature is increased, while in the FTIR spectrum of
the pigSCS112 this is less obvious. Therefore, we wondered whether in
the latter phase separation occurred between the FFA and CER as the
FFA undergoes an orthorhombic to liquid phase transition at elevated
temperatures and thus the shoulder at 730 cm−1 may be due to phase
separated FFA. To examine this, measurements were performed in
which the protonated FFAwas replaced by the deuterated counterparts.
Indeed these studies showed that in the pigSCS112 a fraction of the DFFA
phase separates. However, most probably these DFFA phase separated
domains are still within the same lipid lamellae as only one lamellar
phase is detected by SAXD.
4.3. Lipid organization in SCScontrol and SCSspig
The SCScontrol and SCSspig differ very little in CER subclass composi-
tion and are almost identical. Therefore, the formation of the lamellar
phases in these two mixtures is very similar as illustrated by the SAXD
proﬁles. The FTIR measurements also revealed similar lateral packing
and conformational disordering values for these two mixtures. This
may indicate that, the SCSs prepared from these two lipid mixtures
share the same barrier properties which were conﬁrmed by diffusionstudies: no signiﬁcant differences in permeation ﬂux have been ob-
served between SCScontrol and SCSspig.
4.4. Comparison between present results and previously obtained data
In a previous study, we examined the lipid barrier of SCScontrol and
focused on the change of an orthorhombic–hexagonal lateral phase
transition and the effect on the diffusional barrier [14]. In that previous
study, we performed permeation studies as a function of temperature.
From the slope of the Arrhenius plot the activation energy for diffusion
was calculated. In that study no difference in the slope and thus activa-
tion energywere observed indicating nodifference in diffusion between
the hexagonal lateral packing (higher temperature phase and ortho-
rhombic lateral packing (lower temperature phase). This is different
from the present observation. This could have at least three reasons:
i) in the previous study the model drug benzoic acid was selected, the
ﬂux of which may be less sensitive to changes in the lateral packing,
ii) changes in the activation energy of diffusion were obtained from
the slope of the Arrhenius plot, which is a less sensitive method than
employed in the present study or iii) the solubility of benzoic acid in
the hexagonal phase is higher than in the orthorhombic lateral packing,
which would not affect the activation energy, but will affect the steady
state ﬂux values. In order to compare our current method with the pre-
viously employedmethod for benzoic acid, we have performed an addi-
tional permeation experiment taking benzoic acid as a model drug and
using our current lipid mixtures namely pigSCS111 and pigSCSEOS111
with a hexagonal and orthorhombic packing, respectively. The steady
state ﬂux we obtained for pigSCS111 is 35.4 ± 5.9 μg/cm2/h which is
signiﬁcantly higher than pigSCSEOS111 having a steady state ﬂux of
25.6 ± 4.9 μg/cm2/h. These results demonstrate that the lateral packing
affects the steady state ﬂux not only of hydrocortisone, but also of
benzoic acid and that the lateral packing affects the permeability of
the SCS.
4.5. The importance of chain length in maintaining the lipid barrier
Human SC prevails at a broad chain length distribution, but the pop-
ulation of the shorter chain CER in pig SC is elevated compared to that in
human SC [23,36]. This might be the reason for the increased level of
lipids forming an orthorhombic phase observed in human SC compared
to pig SC [8]. However, previously we also measured mixtures of isolat-
ed pig CERs, CHOL and FFA, in which the FFA had the same composition
as used in the present study. In these studies, we observed the presence
of an orthorhombic packing by wide angle X-ray diffraction, but we
could not examine whether a hexagonal lateral packing was also
present as the single diffraction ring attributed to the hexagonal lateral
packing is obscured by those of the orthorhombic packing [37]. Further-
more, since at that time the pig CER chain length was not analyzed, no
information was available about chain length distribution. A difference
in chain length distribution of the pig CERmixtures used in the previous
and present study may affect the lateral packing. The effect of chain
length distribution on the lateral packing has also been observed in clin-
ical studies where the reduced chain length in CERs correlates with an
increased presence of a hexagonal lateral packing indicative of an al-
tered barrier [13]. Previously, we also studied the effect of reduced
FFA chain length on the lipid barrier of SCS prepared with CERcontrol,
CHOL and short chain FFAs [14]. These studies showed that a reduction
in the FFA chain length makes the packing more hexagonal and also in-
creases the permeation ﬂux several fold, an indication of a reduced bar-
rier function. However, in the latter there was also a change in the
formation of the lamellar phases.
4.6. Extrapolation to the in vivo situation
The studies described in this paper show that i) a wider distribution
of CER chain lengths by including CER with a shorter chain length, ii) a
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lipid barrier function. As the lipid composition mimics very closely
that in SC with natural CERs, we may extrapolate our ﬁnding to the
in vivo situation. As far as the level of CER EO classes are concerned, in
several studies performed with mice knockdown of the genes for the
ELOVL 1, 4 and ceramide synthase 3 [20,38,39] the results show a near
absence of all very long acyl CERs (CER EOS is one of these subclasses).
In these mice there is a drastic increase in the permeability of the skin.
Although the changes in lipid composition and organization are not
the only factors that play a role in the impaired skin barrier function
in these mice, the present study shows that reduced levels of acyl
CERs contribute to a change in the lipid organization (reduced levels
of orthorhombic packing) and subsequently an impaired skin barrier
function. Patients with autosomal recessive congenital ichthyosis also
suffer from an impaired skin barrier function. In these patients a re-
duced ceramide synthase 3 enzyme activity has also been reported to-
gether with a reduced level of acyl CERs [20]. Besides the levels of acyl
CERs, a reduced level of FFAs results in an enhanced presence of thehex-
agonal lateral packing and a reduced lipid barrier. In the SC of lamellar
ichthyosis patients reduced levels of FFAs and an increased level of
lipids adopting the hexagonal lateral packing have been reported. Our
present studies show using natural CERs that these changes may con-
tribute to the impaired skin barrier function in these patients [40,41].
Another interesting group of patients with an impaired skin barrier is
that of atopic dermatitis patients. Recently we observed a reduction in
the average chain length of the CERs that correlated with a reduced
skin barrier [13,42]. Due to a shift in the CER chain lengths toward a
shorter chain length, the chain length distribution is expected to be
wider than in healthy subjects. The present study shows that indeed a
change in chain length distribution toward a shorter chain length may
have a detrimental effect on the skin barrier function. Apart from the re-
duction in CER and FFA chain lengths, the increased level of unsaturated
FFAs as observed in patients with atopic dermatitis and Netherton syn-
drome is also expected to reduce the skin barrier function [43,44]. The
effect of the unsaturated FFAs on the lipid barrier is currently
investigated.
5. Conclusion
Our current studies show that the permeability of SCSs prepared
from PCERs is higher compared to the SCSs prepared from synthetic
CERs demonstrating that a wider chain length distribution of the
PCERs contributes to a reduced lipid barrier. Simultaneously the wider
chain length distribution enhances the formation of a hexagonal lateral
packing, and an increased conformational disordering. These changes in
lipid organization may be responsible for the reduced lipid skin barrier.
Increased levels of CER EOS or FFA in the pigSCSs have an opposite ef-
fect: an improve lipid barrier is monitored, simultaneously with an en-
hanced orthorhombic lateral packing conﬁrming the importance of the
lipid packing and ordering for the lipid barrier.
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